Cannabinoid tolerance relies on CB<sub>1</sub> receptor ubiquitination by NEDD4L.

Álvaro-Blázquez, Alicia; Rodrigues, Rui S; Montero-Fernández, Carlos; Isasa, Marta; Cannich, Astrid; Gisquet, Doriane; Rodríguez-Crespo, Ignacio; Bellocchio, Luigi et al. · Proc Natl Acad Sci U S A · 2026

basic_science · Level V

Where this comes from

Abstract

Cannabinoids, the active components of cannabis, exert numerous acute effects in the brain by engaging cannabinoid CB<sub>1</sub> receptors (CB<sub>1</sub>Rs). However, tolerance emerges rapidly after repeated drug exposure, undermining the efficacy of cannabinoid-based therapies and contributing to cannabis-associated adverse effects. Although the processes of CB<sub>1</sub>R short-term desensitization (i.e., receptor uncoupling and internalization) are well characterized, the mechanisms underlying CB<sub>1</sub>R long-term tolerance (i.e., downregulation of receptor protein levels) remain elusive. Here, we identify a ubiquitin-dependent pathway that couples CB<sub>1</sub>R activation to its proteasomal degradation. We show that cannabinoids engage a G<sub>q/11</sub>-PLC-PKC signaling cascade that phosphorylates and activates the E3 ubiquitin ligase neural precursor cell-expressed developmentally downregulated 4-like (NEDD4L), promoting its recruitment to CB<sub>1</sub>R and the ubiquitination of four specific lysine residues. This modification targets the receptor for proteasomal clearance, reducing neuronal CB<sub>1</sub>R abundance in vitro and in the mouse brain. Using molecular, pharmacological, and circuit-specific rescue approaches, we demonstrate that preventing CB<sub>1</sub>R ubiquitination stabilizes receptor levels and abolishes behavioral cannabinoid tolerance in mice without impairing acute drug responses. These findings reveal a molecular mechanism that controls CB<sub>1</sub>R stability and identify NEDD4L-mediated ubiquitination as a central driver of cannabinoid tolerance.

Medical subject headings